🇺🇸 FDA
Pipeline program

Tolvaptan

156-12-809-01

Phase 3 small_molecule completed

Quick answer

Tolvaptan for Cardiac Edema is a Phase 3 program (small_molecule) at Otsuka Beijing Research Institute with 1 ClinicalTrials.gov record(s).

Program details

Company
Otsuka Beijing Research Institute
Indication
Cardiac Edema
Phase
Phase 3
Modality
small_molecule
Status
completed

Clinical trials